Examining the interplay between depression, motivation, and antiretroviral therapy adherence: a social cognitive approach

Tatum, Alexander K.; Houston, Eric

doi:10.1080/09540121.2016.1220481

Cited by 11 publications

(12 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Anxiety and especially depression have consistently been associated with poor antiretroviral treatment (ART) adherence (Safren et al, 2016;Smith Fawzi et al, 2016;Tao et al, 2016;Tatum & Houston, 2016), and are linked to poor virological control and lower CD4 T cell counts (Amanor-Boadu et al, 2016;Herkenham & Kigar, 2016).…”

Section: Introductionmentioning

confidence: 99%

Comparison of levels of anxiety and depression between women and men living with HIV of a Mexico City clinic

Caballero-Suárez

Rodríguez-Estrada

Candela-Iglesias

et al. 2017

View full text Add to dashboard Cite

Introduction. Studies show that women with HIV have higher depression, anxiety symptoms and worse quality of life than men with HIV, but limited data on mental health status of people living with HIV (PLWH) is available in Mexico, hindering the development of specific mental health interventions. Objective. To compare the frequency and severity of depression and anxiety symptoms between men and women of a HIV specialized clinic of Mexico City. Method. Data were derived from a cross-sectional survey on condom use and serostatus disclosure carried out between 2012-2013. Data from Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and sociodemographic characteristics were included in this study. Non-parametric tests were used to compare sociodemographic, clinical and psychological variables and odds ratio were calculated. Results. 291 PLWH were included, 13.1% (n = 38) were women. Significant differences between genders were found in sociodemographic variables (age, marital status, occupation, education, sexual orientation), but not in clinical variables. Depression symptoms were present in 45% of women versus 18.6% of men (x 2 = 13.17, p < .001) and anxiety symptoms were present in 47.4% of women and 30% of men (x 2 = 4.53, p = .033). In unadjusted analysis, women had 3.5 times higher risk than men of presenting depression symptoms (OR = 3.54, 95% CI = 1.61-7.65, p < .001) and 2 times higher risk of having anxiety symptoms than men (OR = 2.01, 95% CI = 0.98-4.42, p < .033). Discussion and conclusion. An important percentage of participants had depression and anxiety symptoms; women showed greater frequency and severity of symptoms as well as greater socioeconomic vulnerability. Mental health interventions are needed and should take into consideration the gender specific differences.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparison of levels of anxiety and depression between women and men living with HIV of a Mexico City clinic

Caballero-Suárez

Rodríguez-Estrada

Candela-Iglesias

et al. 2017

View full text Add to dashboard Cite

show abstract

“…In several disease states, including HIV, depression has been reported to reduce self-efficacy and self-care, two important constructs associated with retention in care and adherence to ART [ 38 – 40 ]. The literature regarding anxiety and self-efficacy is heterogeneous, with several studies from the heart failure field suggesting that anxiety is not associated with changes in self-efficacy [ 41 ] or may even be associated with increased self-efficacy after controlling for depression [ 42 , 43 ].…”

Section: Discussionmentioning

confidence: 99%

Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa

Cichowitz

Maraba

Hamilton³

et al. 2017

PLoS ONE

View full text Add to dashboard Cite

We sought to assess mental health at the time of antiretroviral therapy (ART) initiation and subsequent retention in care over a six-month follow-up period. A total of 136 people living with HIV in South Africa were administered surveys measuring demographic information and mental health indicators at the time of ART initiation. Follow-up was completed via chart abstraction to assess for six-month outcomes of retention in care and viral suppression. At enrollment, 45/136 (33%), 67/136 (49%), and 45/136 (33%) participants screened positive for depression, anxiety, and alcohol use disorder, respectively. After six months of follow-up, 96/136 (71%) participants remained in care; 35/87 (40.2%) participants who remained in care had a level <50 copies/mL. Those with depression (49% vs. 77% retained; p < 0.01) and those with alcohol use disorder (52% vs. 76% retained; p < 0.01) were less likely to be retained in care. In multivariable logistic regression, depression OR 3.46 (95% CI: 1.33, 7.97; p < 0.01) and alcohol abuse OR 3.89 (95% CI: 1.70, 8.97; p < 0.01) were independently associated with loss from care. These results emphasize the importance of mental health on early ART outcomes and the HIV care continuum.

show abstract

“…The stigma perceived by PLWHA negatively affects their self-esteem and causes an increase in the prevalence of various mental illnesses, especially depression ( 13 , 14 , 15 ).…”

Section: Introductionmentioning

confidence: 99%

The Reliability and Validity of the Turkish Form of Berger Hiv Stigma Scale

Yıldız¹,

Başar²,

Çaman³

et al. 2021

Archives of Neuropsychiatry

View full text Add to dashboard Cite

Objective: HIV-related stigma towards people living with HIV/AIDS (PLWHA) creates a barrier in access to quality health care, affects mental health and leads to poor treatment adherence. Assessment of different components of HIV-related stigma is needed to develop appropriate strategies for prevention and intervention. The aim of this study was to translate and adapt Berger HIV Stigma Scale to Turkish and assess its reliability and validity. Method: The Turkish version of the 40 item, 4-point Likert-type self-report HIV Stigma Scale, as well as Beck Depression Inventory (BDI), Rosenberg Self-Esteem Scale (RSES) and sociodemographic data form were administered to 95 PLWHA. Results: The items of the scale whose face validity was found to be sufficient, were loaded on four factors in the explanatory factor analysis: Internalised Stigmatization (16 items); Concerns with Public Attitudes (12 items); Negative Self Image (9 items); and Disclosure Concerns (8 items). This structure explained 46.71% of the variance after an item was removed based on the analysis. All subscales had acceptable internal consistency with Cronbach’s alpha coefficients .802-.934. BDE scores had moderate positive correlations with Internalized Stigmatization; Concerns with Public Attitudes; Disclosure Concerns subscale scores (r s =0.214, p=0.047; r s =0.295, p=0.006; r s =0.353, p=0.001), and strong positive correlations with Negative Self Image score (r s =0.617, p<0.001). A moderate positive correlation was found between RSES and Negative Self Image subscale score (r s =0.434; p<0.001). Conclusion: Our findings showed that the Turkish form of Berger HIV Stigma Scale is a reliable and valid tool for measuring HIV-related stigma in PLWHA.

show abstract

Examining the interplay between depression, motivation, and antiretroviral therapy adherence: a social cognitive approach

Cited by 11 publications

References 29 publications

Comparison of levels of anxiety and depression between women and men living with HIV of a Mexico City clinic

Comparison of levels of anxiety and depression between women and men living with HIV of a Mexico City clinic

Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa

The Reliability and Validity of the Turkish Form of Berger Hiv Stigma Scale

Contact Info

Product

Resources

About